About the Authors

Mihaela Friciu

Affiliation Faculté de pharmacie, Université de Montréal, Montréal, QC, Canada

Sarra Zaraa

Affiliation Faculté de pharmacie, Université de Montréal, Montréal, QC, Canada

V. Gaëlle Roullin

Affiliation Faculté de pharmacie, Université de Montréal, Montréal, QC, Canada

Grégoire Leclair

gregoire.leclair@umontreal.ca

Affiliation Faculté de pharmacie, Université de Montréal, Montréal, QC, Canada

Competing Interests

Since 2013, Pr. Leclair agreed to conduct a total of 12 stability studies using different drugs in Oral Mix and Oral Mix SF, proprietary vehicles of Medisca Pharmaceutique Inc. All these studies were supported by unrestricted grants from Medisca and were subjected to the conditions detailed in the financial disclosure section of this manuscript. Nine of these studies are now completed and the three other studies are ongoing. This situation does not alter our adherence to PLOS One policies on sharing data and materials. After having read the competing interests policy of PLOS One, the authors report no other competing financial or nonfinancial interests.

Author Contributions

Conceptualization: VGR GL. Data curation: GL. Formal analysis: MF GL. Funding acquisition: GL. Investigation: MF SZ. Methodology: MF VGR GL. Project administration: VGR GL. Resources: GL. Software: GL. Supervision: VGR GL. Validation: MF GL. Visualization: MF GL. Writing – original draft: GL. Writing – review & editing: MF VGR GL.